Synonyms: AZD-3229 | AZD3229
Compound class:
Synthetic organic
Comment: AZD3229 is a lead dual KIT/PDGFRα inhibitor [1]. It was designed for potential to treat gastrointestinal stromal tumours driven by mutations in KIT or platelet-derived growth factor α (PDGFRα).
The chemical structure of AZD3229 is identical to that for the INN ubavitinib (proposed list 132, Feb. 2025). |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[4-[[5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-2-(4-propan-2-yltriazol-1-yl)acetamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
13338 | ubavitinib |
Synonyms ![]() |
AZD-3229 | AZD3229 |
Database Links ![]() |
|
BindingDB Ligand | 50459416 |
CAS Registry No. | 2248003-60-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4216473 |
GtoPdb PubChem SID | 483123251 |
PubChem CID | 134814269 |
RCSB PDB Ligand | F8H |
Search Google for chemical match using the InChIKey | FLJOFQUXYAWOPE-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | FLJOFQUXYAWOPE |
Search PubMed clinical trials | ubavitinib |
Search PubMed titles | ubavitinib |
Search PubMed titles/abstracts | ubavitinib |
UniChem Compound Search for chemical match using the InChIKey | FLJOFQUXYAWOPE-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FLJOFQUXYAWOPE-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
AZD3229 (links to external site)
Cat. No. HY-112802 |